Abstracto

A Review on Bevacizumab: An Anti-Cancer Drug

Jyotsna Jangra

Cancer is one of the most wide spread diseases. Now-a-days, due to the advanced technologies drug for different kinds of cancer are available in the market. Bevacizumab (Avastin) is a one of the well-known anti-cancer drug which is used for different kinds of cancer. Bevacizumab (Avastin) interferes with growth of the cancerous cells. It is a humanized monoclonal antibody drug which blocks angiogenesis by inhibiting Vascular Endothelial Growth Factor A (VEGF-A). Researchers have shown the advantages of this drug in metastatic breast cancer, in blindness, ovarian cancer and many more. Before using this drug, patient should consult to the doctor and should be aware of its side effects in the future.

Descargo de responsabilidad: este resumen se tradujo utilizando herramientas de inteligencia artificial y aún no ha sido revisado ni verificado.

Indexado en

Chemical Abstracts Service (CAS)
Google Académico
Open J Gate
Academic Keys
ResearchBible
The Global Impact Factor (GIF)
CiteFactor
Cosmos SI
Biblioteca de revistas electrónicas
Búsqueda de referencia
Universidad Hamdard
Instituto Internacional de Investigación Organizada (I2OR)
Cosmos
Fundación de Ginebra para la educación e investigación médicas
Laboratorios secretos de motores de búsqueda

Ver más